---
figid: PMC5350330__MI2017-6893560.006
figlink: /pmc/articles/PMC5350330/figure/fig6/
number: F6
caption: AM966 reduces pulmonary microvascular cell barrier integrity through LPA1/Gα12/13-mediated
  phosphorylation of MLC and VE-cadherin. AM966 is ligated to LPA1 and triggers RhoA/Rho
  kinase pathway, thereby increasing MLC phosphorylation and cytoskeletal rearrangement.
  AM966 induces phosphorylation of VE-cadherin. Therefore, AM966 increases lung endothelial
  permeability.
pmcid: PMC5350330
papertitle: AM966, an Antagonist of Lysophosphatidic Acid Receptor 1, Increases Lung
  Microvascular Endothelial Permeability through Activation of Rho Signaling Pathway
  and Phosphorylation of VE-Cadherin.
reftext: Junting Cai, et al. Mediators Inflamm. 2017;2017:6893560.
pmc_ranked_result_index: '78704'
pathway_score: 0.9549956
filename: MI2017-6893560.006.jpg
figtitle: AM966 reduces pulmonary microvascular cell barrier integrity through LPA1/GA12/13-mediated
  phosphorylation of MLC and VE-cadherin
year: '2017'
organisms:
- Homo sapiens
ndex: 9532cfdc-deea-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5350330__MI2017-6893560.006.html
  '@type': Dataset
  description: AM966 reduces pulmonary microvascular cell barrier integrity through
    LPA1/Gα12/13-mediated phosphorylation of MLC and VE-cadherin. AM966 is ligated
    to LPA1 and triggers RhoA/Rho kinase pathway, thereby increasing MLC phosphorylation
    and cytoskeletal rearrangement. AM966 induces phosphorylation of VE-cadherin.
    Therefore, AM966 increases lung endothelial permeability.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MLC1
  - ACTB
  - ACTA2
  - LPAR1
  - ACTG2
  - CDH5
  - RHOA
  - ACTA1
  - ACTC1
  - ACTG1
genes:
- word: MLC
  symbol: MLC
  source: hgnc_alias_symbol
  hgnc_symbol: MLC1
  entrez: '23209'
- word: Actin
  symbol: Actin
  source: bioentities_symbol
  hgnc_symbol: ACTB
  entrez: '60'
- word: Actin
  symbol: Actin
  source: bioentities_symbol
  hgnc_symbol: ACTA2
  entrez: '59'
- word: LPA1
  symbol: LPA1
  source: hgnc_alias_symbol
  hgnc_symbol: LPAR1
  entrez: '1902'
- word: Actin
  symbol: Actin
  source: bioentities_symbol
  hgnc_symbol: ACTG2
  entrez: '72'
- word: VE-cadherin
  symbol: CDH5
  source: hgnc_symbol
  hgnc_symbol: CDH5
  entrez: '1003'
- word: RhoA
  symbol: RhoA
  source: hgnc_alias_symbol
  hgnc_symbol: RHOA
  entrez: '387'
- word: Actin
  symbol: Actin
  source: bioentities_symbol
  hgnc_symbol: ACTA1
  entrez: '58'
- word: Actin
  symbol: Actin
  source: bioentities_symbol
  hgnc_symbol: ACTC1
  entrez: '70'
- word: Actin
  symbol: Actin
  source: bioentities_symbol
  hgnc_symbol: ACTG1
  entrez: '71'
chemicals: []
diseases: []
figid_alias: PMC5350330__F6
redirect_from: /figures/PMC5350330__F6
figtype: Figure
---
